PhilipEdwardLammersMD

Chief of Medical Oncology, Medical Director of Clinical Oncology Research, Medical Oncologist

Overview of Dr. Lammers

Dr. Philip Lammers is an oncologist in Memphis, TN and is affiliated with Baptist Memorial Hospital-Tipton. He received his medical degree from Indiana University School of Medicine and has been in practice 11 years. He is one of 18 doctors at Baptist Memorial Hospital-Tipton who specialize in Oncology. He has more than 30 publications and over 500 citings.

Office
80 Humphreys Center
Suite 330
Memphis, TN 38120
Book by Phone+1(901) 582-8079
Is this information wrong?

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
Indiana University School of MedicineClass of 2006

Certifications & Licensure

TN State Medical License 2009 - 2025
MS State Medical License 2019 - 2024

Clinical Trials

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Pa...
Beckermann, K., El Osta, B., Sanborn, R., Selvaggi, G., Whisenant, J., Heimann-Nichols, E., Berry, L., Hsu, C., Shyr, Y., Horn, L., Bestvina, C., Borghaei, H., Lammers...> ;JTO Clinical and Research Reports. 2024 Feb 1
2 citations
Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Medrxiv. 2023 Mar 10
7 citations
Enhancing Cancer care of rural dwellers through telehealth and engagement (ENCORE): protocol to evaluate effectiveness of a multi-level telehealth-based intervention t...
Tuya Pal, Pamela C. Hull, Tatsuki Koyama, Phillip Lammers, Denise Martinez, Jacob McArthy, Emma Schremp, Ann Tezak, Anne Washburn, Jennifer G. Whisenant, Debra L. Frie...> ;BMC Cancer. 2021 Nov 23
18 citations
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer:...
Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García-Campelo, William Jeffery Edenfield, Trevor M. Feinstein, Jennifer Johnson, Sujith Kalmadi, Ph...> ;Cancer Medicine. 2021 Sep 1
5 citations
Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System.
Meredith Ray, Nicholas Faris, Carrie Fehnel, Anna Derrick, Matthew P. Smeltzer, Meghan Meadows-Taylor, Folabi Ariganjoye, Alicia Pacheco, Robert Optican, Keith Tonkin,...> ;JTO Clinical and Research Reports. 2021 Jul 3
208 citations
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy, Chih-Yuan Hsu, Yu Shyr, X. Li, Toni K. Choueiri, Corrie A. Painter, Solange Peters, Br...> ;Annals of Oncology. 2021 Jun 1
1 citations
Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool.
Smita K. Rao, Kimberly A. Thomas, Rajbir Singh, Eden Biltibo, Philip E. Lammers, Georgia L. Wiesner> ;Journal of Community Genetics. 2021 Jan 1
23 citations
Participant choices for return of genomic results in the eMERGE Network.
Christin Hoell, Julia Wynn, Luke V. Rasmussen, Keith Marsolo, Sharon Aufox, Wendy K. Chung, John J. Connolly, Robert R. Freimuth, David C. Kochan, Hakon Hakonarson, Ma...> ;Genetics in Medicine. 2020 Jul 16
32 citations
Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network
Georgia L. Wiesner, Alanna Kulchak Rahm, Paul S. Appelbaum, Sharon Aufox, Sarah T. Bland, Carrie L. Blout, Kurt D. Christensen, Wendy K. Chung, Ellen Wright Clayton, R...> ;Journal of Personalized Medicine. 2020 Apr 27
77 citations
Harmonizing Clinical Sequencing And Interpretation For The Emerge III Network
Hana Zouk, Eric Venner, Niall J. Lennon, Donna M. Muzny, Debra J. Abrams, Samuel E. Adunyah, Ladia Albertson-Junkans, Darren C. Ames, Paul S. Appelbaum, Samuel J. Aron...> ;American Journal of Human Genetics. 2019 Sep 5
73 citations
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical ...
Ghassan K. Abou-Alfa, Qian Shi, Jennifer J. Knox, Andreas Kaubisch, Donna Niedzwiecki, James Posey, Benjamin R. Tan, Petr Kavan, R. Goel, Philip E. Lammers, Tanios Bek...> ;JAMA Oncology. 2019 Nov 1
43 citations
Bispecific antibodies in the treatment of hematologic malignancies
Johannes Duell, Philip E. Lammers, Ivana Djuretic, Allison Given Chunyk, Shilpa Alekar, Ira Jacobs, Saar Gill> ;Clinical Pharmacology and Therapeutics. 2019 Mar 29
21 citations
Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4
Josiah Ochieng, Gladys N. Nangami, Amos M. Sakwe, Tanu Rana, Shalonda M. Ingram, Jeffrey S. Goodwin, Cierra Moye, Philip E. Lammers, Samuel E. Adunyah> ;FEBS Letters. 2018 Oct 1
37 citations
Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes.
Josiah Ochieng, Gladys N. Nangami, Amos M. Sakwe, Cierra Moye, Joel Alvarez, Diva S. Whalen, Portia L. Thomas, Philip E. Lammers> ;International Journal of Molecular Sciences. 2018 Jul 29
39 citations
Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer
Philip E. Lammers, Magdolna Dank, Riccardo Masetti, Richat Abbas, Fiona Hilton, Jennifer Coppola, Ira Jacobs> ;British Journal of Cancer. 2018 Jul 13
22 citations
High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx.
Duaa Babaer, Suneetha Amara, Michael T. Ivy, Yan Zhao, Philip E. Lammers, Jens Titze, Venkataswarup Tiriveedhi> ;Oncotarget. 2018 May 18
3 citations
A rapidly growing human papillomavirus‑positive oral tongue squamous cell carcinoma in a 21‑year old female: A case report
Ebenezer O. Appah, Billy R. Ballard, Michael G. Izban, Cassandra Jolin, Philip E. Lammers, Dwight D. Parrish, Dana Marshall> ;Oncology Letters. 2018 May 1
28 citations
Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilars.
Christian Jackisch, Philip E. Lammers, Ira Jacobs> ;Breast. 2017 Apr 1
29 citations
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
Bradley J. Monk, Philip E. Lammers, Thomas Cartwright, Ira Jacobs> ;Pharmaceuticals. 2017 Jan 28
15 citations
Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas.
Gladys N. Nangami, Amos M. Sakwe, Michael G. Izban, Tanu Rana, Philip E. Lammers, Portia L. Thomas, Zhenbang Chen, Josiah Ochieng> ;Cancer Medicine. 2016 Nov 1
34 citations
Inhibition of the biosynthesis of prostaglandin E2 by low dose aspirin: implications for adenocarcinoma metastasis.
Olivier Boutaud, I. Romina Sosa, Taneem Amin, David H. Adler, Hyun Seok Hwang, Brenda C. Crews, Ginger L. Milne, Bradford K. Harris, Megan D. Hoeksema, Bjorn C. Knollm...> ;Cancer Prevention Research. 2016 Nov 1
22 citations
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma.
Morton Coleman, Philip E. Lammers, Fabio Ciceri, Ira Jacobs> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Apr 1
Biosimilars: Extrapolating the evidence. A roundtable discussion.
Bradley J. Monk, Morton Coleman, Philip E. Lammers, George Somlo> ;EJC Supplements. 2015 Dec 1
27 citations
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.
Luiz H. Araujo, Philip E. Lammers, Velmalia Matthews-Smith, Rosana Eisenberg, Adriana Gonzalez, Ann G. Schwartz, Cynthia Timmers, Konstantin Shilo, Weiqiang Zhao, Than...> ;Journal of Thoracic Oncology. 2015 Oct 1
15 citations
nab-Paclitaxel in Combination With Weekly Carboplatin With Concurrent Radiotherapy in Stage III Non-Small Cell Lung Cancer
Philip E. Lammers, Bo Lu, Leora Horn, Yu Shyr, Vicki L. Keedy> ;The Oncologist. 2015 May 1
Join now to see all

Press Mentions

Memphis People in Business: March 25, 2021March 25th, 2021
FDA Approves Herceptin Biosimilar Ontruzant for HER2-Positive Breast CancerJuly 24th, 2019
Cancer Disparities Grant with Meharry, TSU Gains RenewalOctober 20th, 2016
Join now to see all